GB201300054D0 - Methods for cartilage repair using TFGBETA and FGF -2 - Google Patents
Methods for cartilage repair using TFGBETA and FGF -2Info
- Publication number
- GB201300054D0 GB201300054D0 GBGB1300054.2A GB201300054A GB201300054D0 GB 201300054 D0 GB201300054 D0 GB 201300054D0 GB 201300054 A GB201300054 A GB 201300054A GB 201300054 D0 GB201300054 D0 GB 201300054D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- tfgbeta
- fgf
- methods
- cartilage repair
- cartilage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention relates to a novel combination of growth factors that induce morphogenic changes in cartilage leading o maturation of the phenotype; and the use of these growth factors in culture medium and therapeutics for repairing damaged cartilage.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201010422A GB201010422D0 (en) | 2010-06-22 | 2010-06-22 | Cartilage repair |
PCT/GB2011/051144 WO2011161437A1 (en) | 2010-06-22 | 2011-06-20 | Methods for cartilage repair using tfgbeta and fgf - 2 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201300054D0 true GB201300054D0 (en) | 2013-02-20 |
GB2494357A GB2494357A (en) | 2013-03-06 |
Family
ID=42582763
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201010422A Ceased GB201010422D0 (en) | 2010-06-22 | 2010-06-22 | Cartilage repair |
GB1300054.2A Withdrawn GB2494357A (en) | 2010-06-22 | 2011-06-20 | Methods for cartilage repair using TFGBETA and FGF -2 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201010422A Ceased GB201010422D0 (en) | 2010-06-22 | 2010-06-22 | Cartilage repair |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB201010422D0 (en) |
WO (1) | WO2011161437A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3660018A4 (en) * | 2017-07-27 | 2021-04-21 | Jiangsu Hengrui Medicine Co., Ltd. | Piperazine heteroaryl derivative, preparation method therefor and use of same in medicine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8017394B2 (en) * | 2004-10-01 | 2011-09-13 | Isto Technologies, Inc. | Method for chondrocyte expansion with phenotype retention |
JP4044579B2 (en) * | 2005-08-02 | 2008-02-06 | 株式会社Pgリサーチ | Artificial cartilage tissue |
JP6156968B2 (en) * | 2008-11-25 | 2017-07-05 | ティシュージーン,インク. | Priming cell therapy |
-
2010
- 2010-06-22 GB GB201010422A patent/GB201010422D0/en not_active Ceased
-
2011
- 2011-06-20 WO PCT/GB2011/051144 patent/WO2011161437A1/en active Application Filing
- 2011-06-20 GB GB1300054.2A patent/GB2494357A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB201010422D0 (en) | 2010-08-04 |
GB2494357A (en) | 2013-03-06 |
WO2011161437A1 (en) | 2011-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273159A (en) | Culture medium composition, and method for culturing cell or tissue using said composition | |
EP2421956A4 (en) | Compositions and methods for deriving or culturing pluripotent cells | |
EP2257176A4 (en) | Compositions and methods for cartilage repair | |
SG11201405875PA (en) | Methods and compositions for regenerating and repairing damaged tissue using nonviable irradiated or lyophilized pluripotent stem cells | |
MX2019002513A (en) | Methods and compositions for consumables. | |
WO2011139688A3 (en) | Methods for generating cardiomyocytes | |
EP2544609A4 (en) | Apparatus and methods for bone repair | |
EP2795293A4 (en) | Spectroscopic means and methods for identifying microorganisms in culture | |
EP2423302A4 (en) | New serum-free medium for inducing pluripotent stem cells quickly with high efficiency and method using thereof | |
EP2734622A4 (en) | Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage | |
EP2608778A4 (en) | Compositions and methods for treating bone defects | |
IL205616A (en) | Compositions containing hepatocyte growth factors for use in the repair or regeneration of damaged myocardium | |
EP2550629A4 (en) | Method and apparatus for managing files in an online account | |
EP2438161B1 (en) | Method for producing induced pluripotent stem cells and method for culturing the same | |
IL212277A0 (en) | Compositions for use in treating thymic stromal lymphopoietin (tslp)-mediated conditions | |
DK2403994T3 (en) | APPARATUS AND METHOD FOR MANAGING RAILWAYS | |
GB201011269D0 (en) | Apparatus and methods for maintenance and repair of vessels | |
AP3121A (en) | Biomass stove apparatus and method for its use | |
EP2448957A4 (en) | Methods and compositions for affecting the differentiation of clostridia in culture | |
EP2399989A4 (en) | Culture medium and method for inducing differentiation into adipocytes | |
EP2616085A4 (en) | Compositions and method for promoting musculoskeletal repair | |
GB201120187D0 (en) | Method and apparatus for repair of subsidence damage | |
HUE050574T2 (en) | Compositions and methods for inducing or enhancing connective tissue repair | |
GB201300054D0 (en) | Methods for cartilage repair using TFGBETA and FGF -2 | |
IL217282A0 (en) | Methods and apparatus for improving plant growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |